Preview this article:

There is no abstract available.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article metrics loading...

Loading full text...

Full text loading...



  1. Baz Morelli A., Becher D., Koernig S., Silva A., Drane D., Maraskovsky E. 2012; ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. J Med Microbiol 61:935–943 [CrossRef]
    [Google Scholar]
  2. Bijker E. M., Sauerwein R. W. 2012; Enhancement of naturally acquired immunity against malaria by drug use. J Med Microbiol 61:904–910[PubMed] [CrossRef]
    [Google Scholar]
  3. Edwards J. E. Jr 2012; Fungal cell wall vaccines: an update. J Med Microbiol 61:895–903[PubMed] [CrossRef]
    [Google Scholar]
  4. Kool M., Fierens K., Lambrecht B. N. 2012; Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol 61:927–934[PubMed] [CrossRef]
    [Google Scholar]
  5. Oyston P. C., Robinson K. 2012; The current challenges for vaccine development. J Med Microbiol 61:889–894[PubMed] [CrossRef]
    [Google Scholar]
  6. Terra V. S., Mills D. C., Yates L. E., Abouelhadid S., Cuccui J., Wren B. W. 2012; Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design. J Med Microbiol 61:919–926[PubMed] [CrossRef]
    [Google Scholar]
  7. Williamson D., Oyston P. C. F. 2012; The natural history and incidence of Yersinia pestis and prospects for vaccination. J Med Microbiol 61:911–918[PubMed] [CrossRef]
    [Google Scholar]
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error